Design, Synthesis, and In-silico Evaluation of Benzyl oxybenzoate Derivatives as Dual HDAC Inhibitors for Cancer and CNS Disorders. Al Mustansiriyah Journal of Pharmaceutical Sciences, [S. l.], v. 25, n. 5, p. 917–930, 2026. DOI: 10.32947/ajps.v25i5.1307. Disponível em: https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/1307. Acesso em: 7 jul. 2026.